Pre-Clinical Testing of T cells Coded with CARs for DIPG |
University of Texas / Laurence Cooper, MD, PhD |
Innovation Grants |
2013 |
Texas |
Mechanisms Regulating Medulloblastoma Progression |
University of Pennsylvania / Nadia Dahmane, PhD |
Innovation Grants |
2013 |
Pennsylvania |
Novel Therapeutic Targets in Relapse T-cell Acute Lymphoblastic Leukemia
|
Massachusetts General Hospital / David Langenau, PhD |
Innovation Grants |
2013 |
Massachusetts |
Therapeutic Targeting of LARG-RhoA Signaling Axis in Childhood Leukemia |
Cincinnati Children's Hospital Medical Center / Yi Zheng, PhD |
Innovation Grants |
2013 |
Ohio |
Reactivating Apoptosis in Refractory Pediatric Cancer by Molecular Inhibition of MCL-1 |
Dana-Farber Cancer Institute / Loren Walensky, MD, PhD |
Innovation Grants |
2013 |
Massachusetts |
Identification of TFAP4 (Transcription Factor AP-4/Activating Enhancer Binding Protein) as a Potential Master Regulator/Synthetic Lethal Gene of MYCN Amplified Neuroblastoma |
Columbia University Medical Center / Darrell Yamashiro, MD, PhD |
Innovation Grants |
2013 |
New York |
An Oncolytic Herpes Simplex Virus Restricted in Entry to Neuroblastoma Cells |
Northwestern University Medical School / Richard Longnecker, PhD |
Innovation Grants |
2013 |
Illinois |
Development of MicroRNA-Nanoparticles to Treat Childhood Acute Leukemia Carrying MLL Rearrangements |
University of Cincinnati College of Medicine / Jianjun Chen, PhD |
Innovation Grants |
2013 |
Ohio |
Engager T cells for the Adoptive Immunotherapy of Pediatric Malignancies |
Baylor College of Medicine / Stephen Gottschalk, MD |
Innovation Grants |
2013 |
Texas |
Multispecific T Cells for Adoptive Immunotherapy of Pediatric High Grade Glioma (HGG) |
Baylor College of Medicine / Nabil Ahmed, MD, MSc |
Innovation Grants |
2013 |
Texas |